2 news items
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
metastatic breast cancer," said Susan Galbraith, Executive Vice President, Oncology R
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
, Oncology R&D, of AstraZeneca. "The results reinforce the potential for Enhertu to improve outcomes
- Prev
- 1
- Next